Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group.
Allison MagnusonSuanna Steeby BruinoogeHarpreet SinghKeith D WilnerShadia JalalStuart M LichtmanPaul G KluetzGary H LymanHeidi D KlepinMark E FleuryBrad HirschAllen MelemedFernanda I ArnaldezUpal Basu RoyCaroline SchenkelShimere SherwoodElizabeth Garrett-MayerPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Expanding PS eligibility criteria to be more inclusive may be justified in many cases and could result in faster accrual rates and more representative trial populations.See related commentary by Giantonio, p. 2369.